More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$260113629
EPS
-0.39
P/E ratio
--
Price to sales
0.56
Dividend yield
--
Beta
0.778255
Previous close
$6.36
Today's open
$15.61
Day's range
$15.60 - $15.67
52 week range
$4.90 - $15.67
show more
CEO
Michael E. Manna
Employees
671
Headquarters
Newark, NY
Exchange
NASDAQ Global Market
Shares outstanding
16663269
Issue type
Common Stock
Industrials
Industrial Goods
ULBI SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES ULTRALIFE CORPORATION
ULBI shareholders will receive just $16.00 per share in a transaction with an enterprise value of approximately $320 million; Ademi LLP is investigating the deal price, benefits to company insiders, and restrictions on competing offers CLICK HERE TO JOIN MILWAUKEE, Oct. 28, 2026 /PRNewswire/ -- Ademi LLP is investigating whether the proposed acquisition of Ultralife (NASDAQ: ULBI) by EnerSys, provides fair value to Ultralife's public shareholders and whether Ultralife's Board adequately protected shareholder interests in negotiating and approving the transaction. Are You a ULBI Shareholder?
PRNewsWire • Oct 28, 2026

ULBI Stock Alert: Halper Sadeh LLC is Investigating Whether Ultralife Corporation is Obtaining a Fair Price for its Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Ultralife Corporation (NASDAQ: ULBI) to EnerSys for $16.00 per share in cash.Halper Sadeh encourages Ultralife shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Ultralife and its board of directors violated the fe.
Business Wire • Oct 28, 2026

Ultralife Stock Soars After EnerSys Agrees to $320M Buyout
Ultralife Corp. (NASDAQ:ULBI) shares more than doubled Wednesday after the battery maker agreed to an all-cash acquisition by EnerSys (NYSE:ENS).
Benzinga • Oct 28, 2026

Ultralife Stock Soars 145%. EnerSys to Buy It for the ‘Battlefield of the Future.
Shares of Ultralife were on pace for their best trading day ever after defense company EnerSys said it will be acquiring the battery systems company for $320 million.
Barrons • Oct 28, 2026

EnerSys to Acquire Ultralife Corporation in a $320 Million All-Cash Transaction
NEWARK, N.Y., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has entered into an Agreement and Plan of Merger (“merger agreement”) with EnerSys (NYSE: ENS) under which upon closing EnerSys will acquire Ultralife Corporation in an all-cash transaction valued at approximately $320 million, including the assumption of net debt.
GlobeNewsWire • Oct 27, 2026

EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market
READING, Pa.--(BUSINESS WIRE)-- #EnerSys--EnerSys (NYSE: ENS), a global leader in stored energy solutions for industrial, infrastructure, and defense applications, today announced that it has entered into a definitive agreement to acquire Ultralife (NASDAQ:ULBI) for $16.00 per share in cash, representing a 166% premium to Ultralife's unaffected closing share price on October 26, 2026. The transaction represents an enterprise value of approximately $320 million. EnerSys expects to realize $15 million to $2.
Business Wire • Oct 27, 2026

Ultralife Upgraded to Neutral on Backlog & Product Commercialization
ULBI's upgrade to Neutral reflects record backlog, product commercialization, manufacturing improvements and broader opportunities from vertical integration.
Zacks Investment Research • Sep 25, 2026

Ultralife: Well Positioned For Liquidity Despite Low Cash And Declining Cash Flow
Ultralife Corporation maintains a Buy rating, supported by strong working capital, declining debt, and improving profitability despite recent cash flow concerns. ULBI's Q2-2026 results show significant year-over-year gains in operating income and adjusted EBITDA, aided by a $1.1 million tariff refund. Liquidity risk is mitigated by a current ratio of 2.9, a quick ratio of 1.11, and management's confidence in converting inventory and receivables into cash.
Seeking Alpha • Sep 21, 2026

Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip
ULBI's earnings improve in second-quarter 2026 despite softer revenues, as stronger margins, record backlog and operational gains supported its profitable-growth outlook.
Zacks Investment Research • Aug 12, 2026

Ultralife Q2 Earnings Call Highlights
Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.
MarketBeat • Aug 7, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Ultralife Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.